Dr. Ryan Flannigan, MD
Claim this profileVancouver Prostate Centre
Studies Chronic Pain
Studies Kidney Stones
4 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Ryan Flannigan, MD is currently running
Sustained Release Lidocaine
for Postoperative Pain
This trial is testing a new slow-release lidocaine formulation (ST-01) to manage pain after certain surgeries. It aims to provide longer-lasting pain relief and reduce the need for opioids. The medication is injected near the surgical site and releases lidocaine over time. Lidocaine has been used in various forms for pain management, including topical systems and systemic infusions, to reduce pain and opioid consumption.
Recruiting1 award Phase 25 criteria
Sustained Release Lidocaine
for Chronic Pain
This multi-center, phase 2, randomized, single-blind, three-arm, active-controlled study is comparing repeat doses, every 28 days, of standard of care (SOC) plus ST-01 against SOC plus 1% lidocaine HCL in men experiencing chronic scrotal content pain (CSCP). The main purpose of this study is to determine if repeat injections of ST-01 are safe and effective in reducing pain. After completing a screening phase participants will be randomized into one of three groups: 1) ST-01 70 mg/mL arm, 2) ST-01 140 mg/mL arm, 3) 1% Lidocaine HCL arm (Control). Participants may receive up to 4 study treatment injections given at a minimum of 28-day intervals. Participants randomized to the Control arm will be given the opportunity to cross over to an ST-01 treatment arm after 2 study treatments.
Recruiting1 award Phase 27 criteria
More about Ryan Flannigan, MD
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Ryan Flannigan, MD has experience with
- ST-01
- 1% Lidocaine HCL
- Ciprofloxacin
- Cotrimoxazole-Trimethoprim
- Macrodantin
- Peer Navigation
Breakdown of trials Ryan Flannigan, MD has run
Chronic Pain
Kidney Stones
Prostate Cancer
Postoperative Pain
Post-Surgical Pain
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ryan Flannigan, MD specialize in?
Ryan Flannigan, MD focuses on Chronic Pain and Kidney Stones. In particular, much of their work with Chronic Pain has involved treating patients, or patients who are undergoing treatment.
Is Ryan Flannigan, MD currently recruiting for clinical trials?
Yes, Ryan Flannigan, MD is currently recruiting for 2 clinical trials in Vancouver British Columbia. If you're interested in participating, you should apply.
Are there any treatments that Ryan Flannigan, MD has studied deeply?
Yes, Ryan Flannigan, MD has studied treatments such as ST-01, 1% Lidocaine HCL, Ciprofloxacin.
What is the best way to schedule an appointment with Ryan Flannigan, MD?
Apply for one of the trials that Ryan Flannigan, MD is conducting.
What is the office address of Ryan Flannigan, MD?
The office of Ryan Flannigan, MD is located at: Vancouver Prostate Centre, Vancouver, British Columbia V5Z 1M9 Canada. This is the address for their practice at the Vancouver Prostate Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.